Ein News
Questions? +1 202-540-8337 Email Form
  • Home
  • Company
  • Services
  • Contact
— The world's leading real-time news index —BETA
447
matching articles
Home | Archive | Cool Tools | About | Contact |
Share
Source: The Center for Biosimilars (remove)
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
7 Jan 2026 21:08 GMT Real-World Study Finds Stable Vision After Switch to Ranibizumab Biosimilar The Center for Biosimilars
7 Jan 2026 02:57 GMT Evidence Supports Safe, Effective Switching to Etanercept Biosimilars The Center for Biosimilars
6 Jan 2026 14:32 GMT FDA Approves Amneal Denosumab Biosimilars, Capping Year of Market Expansion The Center for Biosimilars
5 Jan 2026 21:16 GMT Evidence Gaps Continue to Shape Biosimilar Adoption in Pediatric Care The Center for Biosimilars
31 Dec 2025 22:13 GMT Top 5 Most-Read Biosimilar News of 2025 The Center for Biosimilars
26 Dec 2025 14:52 GMT Top 5 Most-Read Ophthalmology Articles of 2025 The Center for Biosimilars
23 Dec 2025 21:02 GMT BioRationality: Entering a New Era of Affordable Biosimilar Development The Center for Biosimilars
19 Dec 2025 16:50 GMT Top 5 Most-Read Regulatory Articles of 2025 The Center for Biosimilars
18 Dec 2025 15:16 GMT First Natalizumab Biosimilar Tyruko Launches, Expanding Access in Multiple Sclerosis The Center for Biosimilars
17 Dec 2025 01:47 GMT Denosumab, Golimumab Biosimilars Clear Major Regulatory Milestones in Europe, as US Hurdles Remain The Center for Biosimilars
Home | Archive | Cool Tools | About | Contact |
Share
EIN News
Unlimited access to real-time news tracking
Create your EIN News account now.